Cannabidiol metabolism revisited: tentative identification of novel decarbonylated metabolites of cannabidiol formed by human liver microsomes and recombinant cytochrome P450 3A4

被引：11
|
作者：
Watanabe, Kazuhito [1 ]
Usami, Noriyuki [2 ]
Osada, Shigehiro [1 ]
Narimatsu, Shizuo [3 ]
Yamamoto, Ikuo [2 ]
Yoshimura, Hidetoshi [4 ]
机构：
[1] Daiichi Univ Pharm, Minami Ku, 22-1 Tamagawa Cho, Fukuoka, Fukuoka 8158511, Japan
[2] Hokuriku Univ, Fac Pharmaceut Sci, Ho 3 Kanagawa Machi, Kanazawa, Ishikawa 9201181, Japan
[3] Minami Kyushu Univ, Fac Hlth & Nutr, 5-1-2 Kirishima, Miyazaki 8800032, Japan
[4] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
来源：
FORENSIC TOXICOLOGY | 2019年 / 37卷 / 02期
关键词：
Cannabidiol; Decarbonylation; Metabolism; Human liver microsomes; CYP3A4; Cyclopentadienol; CARBON-MONOXIDE; EFFICACY; EPILEPSY;
D O I：
10.1007/s11419-019-00467-0
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
PurposeThe purpose of the present study was to identify the structures of cannabidiol (CBD) metabolites during CO formation by human liver microsomes and human recombinant cytochrome P450 (CYP) enzymes.MethodsCBD was NADPH-dependently metabolized by human liver microsomes and human recombinant CYP enzymes. Less-polar metabolites were analyzed by gas chromatography-mass spectrometry monitoring, and their estimated molecular ions were m/z 286, 358 and 481 after non-derivatization, trimethylsilylation and pentafluorobenzyl oxime formation, respectively.ResultsWe tentatively identified novel decarbonylated metabolites of CBD as keto-enol tautomers. Among eight major recombinant human CYP enzymes, only CYP3A4 catalyzed the formation of decarbonylated metabolites.ConclusionsCBD was biotransformed to two decarbonylated metabolites, an enol-form (cyclopentadienol structure), and a keto-form (cyclopentenone structure) by human liver microsomes and CYP3A4.
引用
收藏
页码：449 / 455
页数：7
相关论文
共 50 条
  • [41] Metabolism of N-methyl, N-propargylphenylethylamine:: Studies with human liver microsomes and cDNA expressed cytochrome p450 (CYP) enzymes
    Rittenbach, Katherine A.
    Holt, Andrew
    Ling, Lei
    Shan, Jackie
    Baker, Glen B.
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2007, 27 (02) : 179 - 190
  • [42] Metabolism of N-Methyl, N-propargylphenylethylamine: Studies with Human Liver Microsomes and cDNA Expressed Cytochrome P450 (CYP) Enzymes
    Katherine A. Rittenbach
    Andrew Holt
    Lei Ling
    Jackie Shan
    Glen B. Baker
    Cellular and Molecular Neurobiology, 2007, 27 : 179 - 190
  • [43] Evaluation of the inhibition of chlorophenols towards human cytochrome P450 3A4 and differences among various species
    Liu, Nai-Rong
    Yang, Kai
    Li, Wen-Ting
    Pang, Zhi-Hua
    Zhang, Qing
    Wang, Jia-Jia
    Dang, Wen-Xi
    Jia, Ruo-Yong
    Fu, Zhi-Wei
    Li, Yi-Xuan
    Yao, Zhu-Hua
    Fang, Zhong-Ze
    SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 724
  • [44] Camptothecin Attenuates Cytochrome P450 3A4 Induction by Blocking the Activation of Human Pregnane X Receptor
    Chen, Yakun
    Tang, Yong
    Robbins, Gregory T.
    Nie, Daotai
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03) : 999 - 1008
  • [45] Metabolism of cytostatically active 6-aminobenzo[c]phenanthridines by human and porcine hepatic microsomes and recombinant cytochrome P450 enzymes
    Zebothsen, I.
    Girreser, U.
    Clement, B.
    XENOBIOTICA, 2006, 36 (07) : 581 - 595
  • [46] Inactivation of Human Cytochrome P450 3A4 and 3A5 by Dronedarone and N-Desbutyl Dronedarone
    Hong, Yanjun
    Chia, Yvonne Mei Fen
    Yeo, Ray Hng
    Venkatesan, Gopalakrishnan
    Koh, Siew Kwan
    Chai, Christina Li Lin
    Zhou, Lei
    Kojodjojo, Pipin
    Chan, Eric Chun Yong
    MOLECULAR PHARMACOLOGY, 2016, 89 (01) : 1 - 13
  • [47] Selective and sensitive quantification of the cytochrome P450 3A4 protein in human liver homogenates through multiple reaction monitoring mass spectrometry
    Cieslak, Anna
    Kelly, Isabelle
    Trottier, Jocelyn
    Verreault, Melanie
    Wunsch, Ewa
    Milkiewicz, Piotr
    Poirier, Guy
    Droit, Arnaud
    Barbier, Olivier
    PROTEOMICS, 2016, 16 (21) : 2827 - 2837
  • [48] Involvement of Cytochrome P450 3A in the Metabolism and Covalent Binding of 14C-Monocrotaline in Rat Liver Microsomes
    Reid, M. J.
    Lame, M. W.
    Morin, D.
    Wilson, D. W.
    Segall, H. J.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 1998, 12 (03) : 157 - 166
  • [49] Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes
    Nakashima, A
    Kawashita, H
    Masuda, N
    Saxer, C
    Niina, M
    Nagae, Y
    Iwasaki, K
    XENOBIOTICA, 2005, 35 (06) : 589 - 602
  • [50] Identification of human cytochrome P450 enzymes involved in the metabolism of a novel κ-opioid receptor agonist, nalfurafine hydrochloride
    Ando, Akihiro
    Oshida, Keiyu
    Fukuyama, Shinichi
    Watanabe, Ayano
    Hashimoto, Hisashi
    Miyamoto, Yohei
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (05) : 257 - 264
12345